Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

35.50

-0.73 (-2.01%)

At close: Feb 24, 2026, 4:00 PM EST

35.40

-0.10 (-0.28%)

Pre-market: Feb 25, 2026, 6:00 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	36.56M	8.78M	12.41M	-	-
Pharmaceuticals Growth	316.34%	-29.22%	-	-	-
Total	36.56M	8.78M	12.41M	-	-
Total Growth	316.34%	-29.22%	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
North America	36.56M	8.78M	-	-	-
North America Growth	316.34%	-	-	-	-
United States	-	-	12.41M	-	-
Total	36.56M	8.78M	12.41M	-	-
Total Growth	316.34%	-29.22%	-	-	-

Source: S&P Global Market Intelligence.